Finanzwire Finanzwire
Basculer en Français
9529 Companies
187435 Keywords
119456 Articles
100182 Press releases
Headlines Articles Press releases POP Biotechnologies, Inc. Remove
  1. Home
  2. Companies
  3. POP Biotechnologies, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/27/2024 at 20:05, 1 year 2 months ago

    POP Biotechnologies Announces Positive Interim Results for COVID-19 Vaccine Trial

    COVID-19 Vaccine Phase 3 Trial Immunogenicity EuCorVac-19 POP BIO SNAP
  • PRESS RELEASE

    published on 09/27/2024 at 20:00, 1 year 2 months ago

    POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM)

    POP Biotechnologies and EuBiologics announce positive findings of ECV-19 COVID-19 vaccine in Phase 3 trial in the Philippines, demonstrating safety, immunogenicity, and potential against Omicron variant
    COVID-19 Vaccine Phase 3 Trial POP Biotechnologies EuBiologics ECV-19
    Logo of POP Biotechnologies, Inc.
  • PRESS RELEASE

    published on 07/14/2023 at 18:00, 2 years 5 months ago

    POP Biotechnologies and EuBiologics' EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial

    Logo of POP Biotechnologies, Inc.
Accesswire
  • Published on 12/15/2025 at 16:35, 51 minutes ago

    Stillwater Critical Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$15 Million

  • Published on 12/15/2025 at 15:00, 2 hours 26 minutes ago

    Kingfisher Reports Annual General Meeting Voting Results

  • Published on 12/15/2025 at 15:00, 2 hours 26 minutes ago

    Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

  • Published on 12/15/2025 at 14:30, 2 hours 56 minutes ago

    Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix

  • Published on 12/15/2025 at 14:00, 3 hours 26 minutes ago

    Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum

View all ACCESSWIRE
EQS Group
  • Published on 12/15/2025 at 17:15, 11 minutes ago

    His Highness Sheikh Mansour bin Zayed Al Nahyan Launches "Al Khail Square" at Abu Dhabi Equestrian Club

  • Published on 12/15/2025 at 17:05, 21 minutes ago

    Gensyn Launches $AI Token Sale on Sonar

  • Published on 12/15/2025 at 16:42, 44 minutes ago

    EQS-Adhoc: Vitruvia Medical AG: successfull capital increase and strengthening of the financial structure

  • Published on 12/15/2025 at 16:08, 1 hour 18 minutes ago

    Conversion of The Platform Group AG into a KGaA completed as planned

  • Published on 12/15/2025 at 15:50, 1 hour 35 minutes ago

    Original-Research: Cabka N.V. (von First Berlin Equity Research GmbH): Kaufen

View all EQS
Les Echos
  • Published on 12/15/2025 at 11:50, 5 hours 36 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025

  • Published on 12/12/2025 at 18:00, 2 days 23 hours ago

    Disclosure of trading in own shares between November 24th and November 28th, 2025

  • Published on 12/12/2025 at 09:15, 3 days 8 hours ago

    CHANGE IN THE SHARE CAPITAL

  • Published on 12/11/2025 at 19:23, 3 days 22 hours ago

    Eiffage is joining the CAC 40 index

  • Published on 12/11/2025 at 08:30, 4 days 8 hours ago

    Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2025 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy